EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy

Sonu Kumar Gupta, Priyanka Singh, Villayat Ali, Malkhey Verma

Oncology Reviews · 06.07.2020 · 14 (2)

DOI: 10.4081/oncol.2020.448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reviews, online erschienen am 06.07.2020. Verfasst von Sonu Kumar Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Basic & Applied Sciences, Central University of Punjab, Punjab, India. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the major problems being faced by researchers and clinicians in leukemic treatment is the development of multidrug resistance (MDR) which restrict the action of several tyrosine kinase inhibitors (TKIs). MDR is a major obstacle to the success of cancer chemotherapy. The mechanism of MDR involves active drug efflux transport of ABC superfamily of proteins such as Pglycoprotein (P-gp/ABCB1), multidrug resistance-associated protein 2 (MRP2/ABCC2), and breast cancer resistance protein (BCRP/ABCG2) that weaken the effectiveness of chemotherapeutics and negative impact on the future of anticancer therapy. In this review, the authors aim to provide an overview of various multidrug resistance (MDR) mechanisms observed in cancer cells as well as the various strategies developed to overcome these MDR. Extensive studies have been carried out since last several years to enhance the efficacy of chemotherapy by defeating these MDR mechanisms with the use of novel anticancer drugs that could escape from the efflux reaction, MDR modulators or chemosensitizers, multifunctional nanotechnology, and RNA interference (RNAi) therapy.

Schlagwörter

Stichwörter der Autor:innen

ABC transporterP-glycoproteinbreast cancer resistance protein (BCRP)chronic myeloid leukemia (CML)multidrug resistance (MDR)

Autor:innen und Institutionen

  • Department of Biochemistry, School of Basic & Applied Sciences, Central University of Punjab, Punjab, India.

Zitieren

APA

Gupta, S. K., Singh, P., Ali, V., & Verma, M. (2020). Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncology Reviews, 14(2). https://doi.org/10.4081/oncol.2020.448

Vancouver

Gupta SK, Singh P, Ali V, Verma M. Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncology Reviews. 2020;14(2). doi:10.4081/oncol.2020.448

BibTeX
@article{Gupta2020,
  author = {Gupta, Sonu Kumar and Singh, Priyanka and Ali, Villayat and Verma, Malkhey},
  title = {Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy},
  journal = {Oncology Reviews},
  year = {2020},
  volume = {14},
  number = {2},
  doi = {10.4081/oncol.2020.448}
}
Kostenlos starten →